Coming Soon: Portfolio Payout Program — paid subscribers earn a share of returns above market benchmarks.Learn more
IE
Insider Edges
Portfolio Analysis

Bruce Kovner Portfolio March 2026 - Top Holdings & 13F Analysis

Analysis of Bruce Kovner's March 2026 13F portfolio with 11 holdings worth $0.0B. +127.6% 1-year return.

March 14, 2026Updated Mar 14, 20265 min readBruce Kovner

Portfolio Value

$0.00B

Total Holdings

11

1-Year Return

+127.6%

New Positions

2

About Bruce Kovner and CAXTON CORP

Bruce Kovner is the portfolio manager at CAXTON CORP, one of the closely tracked institutional investors in our database. Every quarter, institutional investment managers with over $100 million in assets under management are required to file a 13F report with the SEC, disclosing their long equity positions. These filings give retail investors a rare window into how professional money managers are allocating capital.

As of March 2026, Bruce Kovner's 13F portfolio contains 11 positions with a disclosed market value of approximately $0.00 billion. This analysis covers their top holdings, recent portfolio changes, and key investment themes.

Over the past year, Bruce Kovner's portfolio has delivered a +127.6% return, significantly outperforming the broader market.

Bruce Kovner's Top 10 Holdings — March 2026

The following table shows Bruce Kovner's largest disclosed stock positions ranked by portfolio weight as reported in the most recent 13F filing. These represent the highest-conviction bets in the portfolio:

# Company Ticker Portfolio Weight Market Value Performance
1
SPDR GOLD TR
GLD 6449.56% $2.8M +11.5%
2
BERKSHIRE HATHAWAY INC DEL
BRK-B 833.73% $0.4M -0.0%
3
SPYRE THERAPEUTICS INC NEW ADDED
SYRE 682.82% $0.3M
4
MIND MEDICINE MINDMED INC
MNMD 490.88% $0.2M +13.6%
5
KYVERNA THERAPEUTICS INC
KYTX 412.38% $0.2M +56.7%
6
COMPASS THERAPEUTICS INC
CMPX 370.13% $0.2M +53.4%
7
LEXEO THERAPEUTICS INC
LXEO 323.55% $0.1M +49.5%
8
X4 PHARMACEUTICALS INC NEW ADDED
XFOR 145.42% $0.1M
9
INHIBIKASE THERAPEUTICS INC ADDED
IKT 136.31% $0.1M +26.5%
10
SAB BIOTHERAPEUTICS INC
SABS 92.01% $0.0M +86.1%

Data sourced from SEC 13F filings. Holdings reflect disclosed long equity positions. Options and short positions may not be reflected.

Portfolio Strategy & Concentration Analysis

Bruce Kovner's investment approach reflects a highly concentrated portfolio strategy. The top position, SPDR GOLD TR (GLD), represents 6449.6% of the total portfolio, while the top 5 holdings collectively account for 8869.4% of disclosed assets.

During this period, Bruce Kovner initiated 2 new positions — a signal that they identified compelling entry points in new opportunities. New positions often represent the highest-conviction ideas as managers dedicate fresh capital to them.

Additionally, Bruce Kovner increased stakes in 2 existing positions, a sign of growing conviction in those holdings.

New Positions Added in March 2026

The following stocks represent new entries in Bruce Kovner's portfolio — positions that were not present in the prior quarter's 13F filing. New positions are closely watched by investors as they signal fresh conviction:

Company Ticker Portfolio Weight Market Value
SPYRE THERAPEUTICS INC SYRE 682.82% $0.3M
X4 PHARMACEUTICALS INC XFOR 145.42% $0.1M

Best Performing Holdings in Bruce Kovner's Portfolio

Based on available performance data, the following positions have been the strongest contributors to Bruce Kovner's portfolio returns:

1
SABS

SAB BIOTHERAPEUTICS INC

+86.1%
2
KYTX

KYVERNA THERAPEUTICS INC

+56.7%
3
CMPX

COMPASS THERAPEUTICS INC

+53.4%
4
CNTX

CONTEXT THERAPEUTICS INC

+51.7%
5
LXEO

LEXEO THERAPEUTICS INC

+49.5%

Understanding Bruce Kovner's 13F Filing

A 13F filing is a quarterly disclosure required by the SEC for institutional investment managers that exercise discretion over $100 million or more in qualifying securities. These filings must be submitted within 45 days of the end of each calendar quarter.

Important caveats about 13F data:

  • Data is delayed by up to 45 days from the end of the quarter
  • Only long equity positions are disclosed — short positions are not required
  • Options positions are disclosed separately and may indicate hedging strategies
  • The portfolio may have changed significantly since the filing date
  • Not all positions need to be disclosed (some confidentiality provisions exist)

Despite these limitations, 13F filings remain one of the best public sources of information on how professional investors are positioning their portfolios. Use this data as one input among many, alongside your own research and risk tolerance.

How Retail Investors Can Use This Information

Following institutional 13F filings like Bruce Kovner's can provide valuable investment insights — but it's important to use this information correctly:

  • Identify high-conviction ideas: Large positions and new entries signal where managers have the strongest conviction.
  • Spot emerging themes: Cross-portfolio analysis reveals sector rotations and macro themes playing out across institutional money.
  • Validate your own research: If an investor you respect owns a stock you're analyzing, that can reinforce your thesis.
  • Track changes over time: Watching a manager increase or decrease positions over multiple quarters shows conviction trends.
  • Don't blindly copy trades: Remember that institutional investors have different time horizons, risk tolerances, and information than retail investors.

You can track Bruce Kovner's complete portfolio in real-time on Insider Edges, including historical holdings, sector breakdown, and performance data.

Other Top Investors to Follow

If you track Bruce Kovner's portfolio, you may also be interested in following these other closely watched institutional investors:

Track Bruce Kovner's Portfolio in Real-Time

Get notified when new 13F filings drop, access the complete holdings breakdown, and track portfolio changes over time with Insider Edges.

Track Bruce Kovner's Full Portfolio

View all holdings, recent trades, and performance data for CAXTON CORP

View Portfolio

Get Monthly Hedge Fund Alerts

Be the first to know when new 13F filings drop and get monthly portfolio analysis straight to your inbox.

Related Articles